DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

Issue 02 · Volume 41 · March 2015 DOI: 10.1055/s-005-28719 Anticoagulant Therapy: Present and Future Guest Editor: Job Harenberg, MD.

Preface

  • 109
    Favaloro, Emmanuel J.:

    Anticoagulant Therapy: Present and Future

  • 113
    Agnelli, Giancarlo; Prandoni, Paolo; Di Minno, Giovanni; Cimminiello, Claudio; Scaglione, Francesco; Boracchi, Patrizia; Molteni, Mauro; Polo Friz, Hernan; Di Minno, Matteo Nicola Dario; Marano, Giuseppe:

    Thromboprophylaxis with Low-Molecular-Weight Heparins: An Assessment of the Methodological Quality of Studies

  • 133
    Prandoni, Paolo; Lensing, Anthonie W. A.; Prins, Martin H.; Pesavento, Raffaele; Piccioli, Andrea; Sartori, Maria T.; Tormene, Daniela; Milan, Marta; Vedovetto, Valentina; Noventa, Franco; Villalta, Sabina; Harenberg, Job:

    The Impact of Residual Thrombosis on the Long-Term Outcome of Patients with Deep Venous Thrombosis Treated with Conventional Anticoagulation

  • 141
    Dahl, Ola E.; Harenberg, Job; Wexels, Fredrik; Preissner, Klaus T.:

    Arterial and Venous Thrombosis following Trauma and Major Orthopedic Surgery: Molecular Mechanisms and Strategies for Intervention

  • 146
    Senoo, Keitaro; Lip, Gregory Y. H.:

    Comparative Efficacy and Safety of the Non–Vitamin K Antagonist Oral Anticoagulants for Patients with Nonvalvular Atrial Fibrillation

  • 154
    Prandoni, Paolo; Milan, Marta; Barbar, Sofia; Sarolo, Lucia; Piovella, Chiara; Pesavento, Raffaele; Bilora, Franca:

    Incidence of Arterial Embolism in Patients on Treatment with Old and New Anticoagulants for Venous Thromboembolism

  • 160
    Schulman, Sam:

    Treatment of Venous Thromboembolism with New Oral Anticoagulants According to Patient Risk

  • 166
    Zolfaghari, Shabnam; Harenberg, Job; Frölich, Lutz; Weiss, Christel; Wehling, Martin; Wild, Philip; Prochaska, Jürgen; Beyer-Westendorf, Jan; Koscielny, Jürgen; Lip, Gregory Y. H.:

    Development of Recommendations to Continue Anticoagulation with One of the Two Types of Oral Anticoagulants Based on the Identification of Patients' Preference

    Open Access
  • 178
    Riva, Nicoletta; Ageno, Walter:

    Pros and Cons of Vitamin K Antagonists and Non–Vitamin K Antagonist Oral Anticoagulants

  • 188
    McMahon, Brandon J.; Kwaan, Hau C.:

    The New or Non–Vitamin K Antagonist Oral Anticoagulants: What Have We Learned Since Their Debut

  • 195
    Chin, Paul K. L.:

    Which Patients May Benefit from Dose Adjustment of Non-Vitamin K Antagonist Oral Anticoagulants?

  • 208
    Favaloro, Emmanuel J.; Lippi, Giuseppe:

    Laboratory Testing in the Era of Direct or Non–Vitamin K Antagonist Oral Anticoagulants: A Practical Guide to Measuring Their Activity and Avoiding Diagnostic Errors

  • 228
    Harenberg, Job; Du, Shanshan; Krämer, Sandra; Weiss, Christel; Krämer, Roland; Wehling, Martin:

    Patients' Serum and Urine as Easily Accessible Samples for the Measurement of Non–Vitamin K Antagonist Oral Anticoagulants

    Open Access
  • 237
    Wu, Cynthia; Lee, Agnes Y. Y.:

    Novel or Non–Vitamin K Antagonist Oral Anticoagulants and the Treatment of Cancer-Associated Thrombosis

  • 244
    Gerber, Ursula; Hoß, Sebastian G.; Shteingauz, Anna; Jüngel, Eva; Jakubzig, Bastian; Ilan, Neta; Blaheta, Roman; Schlesinger, Martin; Vlodavsky, Israel; Bendas, Gerd:

    Latent Heparanase Facilitates VLA-4–Mediated Melanoma Cell Binding and Emerges As a Relevant Target of Heparin in the Interference with Metastatic Progression

  • 255
    Lippi, Giuseppe; Harenberg, Job; Mattiuzzi, Camilla; Favaloro, Emmanuel J.:

    Next Generation Antithrombotic Therapy: Focus on Antisense Therapy against Coagulation Factor XI